Compared with the COX-2-1759AG genotype, GG genotype carriers had an increased risk of migraine (odds ratio (OR) = 8.720, 95% confidence interval (CI): 1.072–70.960, P = 0.038). Here, PTGS2 is linked to migraine disorder.